BeStock  
Stocks › Medical Distribution › COR

Cencora COR

US equityMarket cap rank #350Medical Distribution
$333.56 −$6.12 (-1.80%)
Pre-market · Nov 9, 4:40 am ET · After hours $333.56 0.00%
Open$333.61
Prev close$339.68
Day range$332.67 – $338.54
Volume1.68M
Market cap$63.65B
P/E (TTM)18.6
Dividend yield0.72%

Earnings

Average move on report day±5.1%last 12 reports
Closed higher8 of 1267% of the time
Best reaction+5.5%
Worst reaction-17.4%

Stock move on the day after each report

+2.6%2023/Q4+5.5%2024/Q1-4.1%2024/Q2+3.0%2024/Q3+4.9%2024/Q4+0.7%2025/Q1+4.7%2025/Q2-2.9%2025/Q3+2.7%2025/Q4-8.8%2026/Q1-17.4%2026/Q2+3.6%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q35 Aug 2026Pre Market±6.7%+3.57%Within range
2026/Q26 May 2026Pre Market±4.6%-17.38%Bigger than priced
2026/Q14 Feb 2026Pre Market±4.7%-8.79%Bigger than priced
2025/Q45 Nov 2025Pre Market±5.1%+2.75%Within range
2025/Q36 Aug 2025Pre Market±6.5%-2.93%Within range
2025/Q27 May 2025Pre Market±5.8%+4.74%Within range
2025/Q15 Feb 2025Pre Market±5.8%+0.68%Within range
2024/Q46 Nov 2024Pre Market±6.8%+4.87%Within range
2024/Q331 Jul 2024Pre Market±5.5%+2.97%Within range
2024/Q21 May 2024Pre Market±5.2%-4.12%Within range
2024/Q131 Jan 2024Pre Market±5.0%+5.51%Bigger than priced
2023/Q42 Nov 2023Pre Market±5.5%+2.64%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • U.S. Healthcare Solutions$74.86B 88.3%
  • International Healthcare Solutions$7.68B 9.1%
  • Other$2.25B 2.7%

Fundamentals

Full statements →

Latest reported quarter: Q3, ended Jun 2026

Revenue$84.75B+5.1% YoY
Operating profit$1.21B+23.0% YoY
Net profit$776.67M+12.6% YoY
Diluted EPS$3.94+11.9% YoY
Free cash flow$2.43B+3,382.5% YoY
Operating cash flow$2.65B

Revenue, last 8 quarters

$79.1BSep '24$81.5BDec '24$75.5BMar '25$80.7BJun '25$83.7BSep '25$85.9BDec '25$78.4BMar '26$84.8BJun '26

Net profit, last 8 quarters

$7.5MSep '24$493.7MDec '24$717.4MMar '25$689.7MJun '25$-333.1MSep '25$566.1MDec '25$1.6BMar '26$776.7MJun '26

Profitability & balance sheet

Gross margin4.0%
Operating margin1.4%
Net margin0.8%
Return on equity104.3%
Return on assets3.3%
Return on invested capital23.5%
Current ratio0.93
Liabilities / assets96.1%
Cash & investments$2.82B
Total debt$11.72B
Net cash (debt)-$8.91B
Free cash flow / sales1.2%

Discussion

No comments yet — be the first to weigh in on COR.

Sign in to join the discussion.

Scroll to Top